PDF herunterladen
Horm Metab Res 2019; 51(05): 288-295
DOI: 10.1055/a-0887-0205
Review
© Georg Thieme Verlag KG Stuttgart · New York

Effect of Calcium‑Vitamin D Co‑Supplementation on Insulin, Insulin Sensitivity, and Glycemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Omid Asbaghi
1   Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Mohammad Zeinali Khosroshahi
1   Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Sara Kashkooli
1   Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Amir Abbasnezhad
1   Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 17. Januar 2019

accepted 27. März 2019

Publikationsdatum:
09. Mai 2019 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effect of calcium-vitamin D co‑supplementation on insulin, insulin sensitivity, and glycemia. A systematic search was carried out in Web of Science, PubMed, EMBASE, Scopus, and Cochrane library without any language and time restriction up to 12 August 2018, to retrieve the RCTs, which examined the effect of calcium and vitamin D co-supplementation on fasting blood glucose (FBG), insulin, HOMA-B, HOMA-IR, and QUICKI. Meta-analyses were carried out using a random effects model, and I2 indexes were used to evaluate the heterogeneity. Search yielded 2225 publications. Twelve RCTs with 4395 patients were eligible. Results demonstrated that calcium and vitamin D co‑supplementation had significantly reducing effects on FBG, HOMA-IR and circulating levels of insulin. As the subgroup analysis demonstrated, short-term (≤12 weeks) calcium and vitamin D co‑supplementation had a significant reducing effect on FBG. However, beneficial effects of calcium and vitamin D co‑supplementation on circulating level of insulin and HOMA-IR were seen in both short-term and long-term (>12 weeks) supplementations. Furthermore, we found that high doses of vitamin D and calcium co-supplementation (vitamin D≥2000 mg/day and calcium≥1000 mg/day) had significantly reducing effects on FBG, HOMA-IR and insulin. Present meta-analysis indicated the beneficial effects of high-dose and short-term combined vitamin D and calcium supplementation on insulin, insulin resistance and glycemia; however, further large-scale RCTs with adequate and multiple dosing schedules are needed.

Key words

vitamin D - calcium - glucose - insulin - systematic review - meta-analysis

Supplementary Material

    Supplementary Material for this article is available online at http://www.thieme-connect.de/products
  • Supplementary Material
 

  • References

  • 1 Reaven GM. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 1993; 44: 121-131
    CrossrefPubMedGoogle Scholar
  • 2 Narayan KM, Boyle JP, Geiss LS. et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006; 29: 2114-2116
    CrossrefPubMedGoogle Scholar
  • 3 Rathmann W, Giani G. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 2568-2569. author reply 2569
    CrossrefPubMedGoogle Scholar
  • 4 [Anonymous] . Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545-1602
    CrossrefPubMedGoogle Scholar
  • 5 Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. PharmacoEconomics 2015; 33: 811-831
    CrossrefPubMedGoogle Scholar
  • 6 Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473-486
    CrossrefPubMedGoogle Scholar
  • 7 [Anonymous] . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853
    CrossrefPubMedGoogle Scholar
  • 8 Kirkman MS, Mahmud H, Korytkowski MT. Intensive Blood glucose control and vascular outcomes in patients with type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2018; 47: 81-96
    CrossrefPubMedGoogle Scholar
  • 9 Akbari M, Ostadmohammadi V, Lankarani KB. et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism 2018; 87: 56-69
    CrossrefPubMedGoogle Scholar
  • 10 Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18: 153-165
    CrossrefPubMedGoogle Scholar
  • 11 Chuang JC, Cha JY, Garmey JC. et al. Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 2008; 22: 2353-2363
    CrossrefPubMedGoogle Scholar
  • 12 Zostautiene I, Jorde R, Schirmer H. et al. Genetic variations in the vitamin d receptor predict type 2 diabetes and myocardial infarction in a community-based population: The Tromso Study. PloS one 2015; 10: e0145359
    CrossrefPubMedGoogle Scholar
  • 13 Li L, Wu B, Liu JY. et al. Vitamin D receptor gene polymorphisms and type 2 diabetes: A meta-analysis. Arch Med Res 2013; 44: 235-241
    CrossrefPubMedGoogle Scholar
  • 14 Ryu OH, Lee S, Yu J. et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J 2014; 61: 167-176
    CrossrefPubMedGoogle Scholar
  • 15 Jehle S, Lardi A, Felix B. et al. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: A randomised, placebo-controlled, prospective pilot study. Swiss Med Weekly 2014; 144: w13942
    PubMedGoogle Scholar
  • 16 Nigil Haroon N, Anton A, John J. et al. Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: A systematic review of interventional studies. J Diabetes Metab Disord 2015; 14: 3
    CrossrefPubMedGoogle Scholar
  • 17 Pittas AG, Lau J, Hu FB. et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029
    CrossrefPubMedGoogle Scholar
  • 18 Pittas AG, Harris SS, Stark PC. et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 2007; 30: 980-986
    CrossrefPubMedGoogle Scholar
  • 19 De Boer IH, Tinker LF, Connelly S. et al. Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women's Health Initiative. Diabetes Care 2008; 31: 701-707
    CrossrefPubMedGoogle Scholar
  • 20 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151: 264-269
    CrossrefPubMedGoogle Scholar
  • 21 Jadad AR, Moore RA, Carroll D. et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17: 1-12
    CrossrefPubMedGoogle Scholar
  • 22 Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
    CrossrefPubMedGoogle Scholar
  • 23 Fedorov S. GetData graph digitizer. available at www.getdata-graph-digitizer.com 2008
    PubMed
  • 24 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557
    CrossrefPubMedGoogle Scholar
  • 25 Major GC, Alarie F, Doré J. et al. Supplementation with calcium+vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations–. Am J Clin Nutr 2007; 85: 54-59
    PubMedGoogle Scholar
  • 26 Mitri J, Dawson-Hughes B, Hu FB. et al. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494
    CrossrefPubMedGoogle Scholar
  • 27 Asemi Z, Tabassi Z, Heidarzadeh Z. et al. Effect of calcium-vitamin D supplementation on metabolic profiles in pregnant women at risk for pre-eclampsia: a randomized placebo-controlled trial. Pak J Biol Sci 2012; 15: 316-324
    CrossrefPubMedGoogle Scholar
  • 28 Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: A randomised placebo-controlled trial. Diabetologia 2014; 57: 1798-1806
    CrossrefPubMedGoogle Scholar
  • 29 Tabesh M, Azadbakht L, Faghihimani E. et al. Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: A randomised controlled clinical trial. Diabetologia 2014; 57: 2038-2047
    CrossrefPubMedGoogle Scholar
  • 30 Asemi Z, Foroozanfard F, Hashemi T. et al. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 2015; 34: 586-592
    CrossrefPubMedGoogle Scholar
  • 31 Foroozanfard F, Jamilian M, Bahmani F. et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol 2015; 83: 888-894
    CrossrefPubMedGoogle Scholar
  • 32 Asemi Z, Samimi M, Siavashani MA. et al. Calcium-vitamin D co-supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. Int J Prev Med 2016; 7: 49
    CrossrefPubMedGoogle Scholar
  • 33 Muhammad J, Chan ES. Brown TT et al. Vitamin D supplementation does not affect metabolic changes seen with ART initiation. Open Forum Infect Dis 2017; 4 ofx210; DOI: 10.1093/ofid/ofx210. eCollection 2017 Fall
    CrossrefPubMedGoogle Scholar
  • 34 Samimi M, Kashi M, Foroozanfard F. et al. The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia. J Hum Nutr Diet 2016; 29: 505-515
    CrossrefPubMedGoogle Scholar
  • 35 Sung CC, Liao MT, Lu KC. et al. Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012; 2012: 634195
    PubMedGoogle Scholar
  • 36 George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis. Diabet Med 2012; 29: e142-e150
    CrossrefPubMedGoogle Scholar
  • 37 Wu C, Qiu S, Zhu X. et al. Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Metabolism 2017; 73: 67-76
    CrossrefPubMedGoogle Scholar
  • 38 Harinarayan CV. Vitamin D and diabetes mellitus. Hormones (Athens, Greece) 2014; 13: 163-181
    CrossrefPubMedGoogle Scholar
  • 39 Riachy R, Vandewalle B, Moerman E. et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 2006; 11: 151-159
    CrossrefPubMedGoogle Scholar
  • 40 Pittas AG, Harris SS, Stark PC. et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-986
    CrossrefPubMedGoogle Scholar
  • 41 Bischoff-Ferrari HA, Giovannucci E, Willett WC. et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28
    CrossrefPubMedGoogle Scholar
  • 42 Pittas AG, Dawson-Hughes B, Li T. et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-656
    CrossrefPubMedGoogle Scholar
  • 43 Li X, Liu Y, Zheng Y. et al. The effect of vitamin d supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients 2018; 10 pii E375 doi:10.3390/nu10030375
    CrossrefPubMedGoogle Scholar
  • 44 Fleming KH, Heimbach JT. Consumption of calcium in the U.S.: Food sources and intake levels. J Nutr 1994; 124: 1426s-1430s
    CrossrefPubMedGoogle Scholar
  • 45 Lau EM, Suriwongpaisal P, Lee JK. et al. Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res 2001; 16: 572-580
    CrossrefPubMedGoogle Scholar
  • 46 Lee CJ, Iyer G, Liu Y. et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complicat 2017; 31: 1115-1126
    CrossrefPubMedGoogle Scholar